_id

695fbe26c2e91020a7bd441f

Ticker

0LOV.LSE

Name

Verastem, Inc.

Exchange

LSE

Address

117 Kendrick Street, Needham, MA, United States, 02494

Country

UK

Sector

Industry

Currency

USD

Website

https://www.verastem.com

Description

Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States. Its product candidates are Avutometinib, an orally available small molecule RAF/MEK clamp that inhibits the ras sarcoma RAF/MEK, ERK mitogen activated pathway kinase pathway which is involved in cell proliferation, migration, transformation, and survival of tumor cells; and Defactinib, an oral small molecule inhibitor of FAK and proline-rich tyrosine kinase for various solid tumors. The company is involved in clinical studies, including RAMP 301, a randomized global confirmatory trial to evaluate the combination of Avutometinib and Defactinib for the treatment of patients with recurrent low-grade serous ovarian cancer; RAMP 201, an adaptive two-part multicenter, parallel cohort, randomized open label trial to evaluate the efficacy and safety of Avutometinib and in combination with Defactinib; and FRAME, an investigation of Avutometinib and Defactinib in patients with KRAS mutant cancers and subsequent analyses; and RAMP 204 and 205. It has license agreements with Chugai Pharmaceutical Co., Ltd. for the development, commercialization, and manufacture of products containing Avutometinib; and Pfizer Inc. to research, develop, manufacture, and commercialize products containing Pfizer's inhibitors of FAK for therapeutic, diagnostic, and prophylactic uses in humans. In addition, it has a clinical collaboration agreement with Amgen, Inc. to evaluate the combination of Avutometinib with Amgen's KRAS-G12C inhibitor LUMAKRAS which in Phase 1/2 trial entitled RAMP 203; and a discovery and development collaboration with GenFleet Therapeutics to advance new programs targeting RAS pathway-driven cancers. Verastem, Inc. was incorporated in 2010 and is headquartered in Needham, Massachusetts.

Last Close

7.67

Volume

400

Current Price

7.67

Change

0.67

Last Updated

2026-01-08T14:24:38.006Z

Ipo Date

-

Market Cap

53242233600

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-

Sentiment Sources

0

Current Quarter

2025-09-30

Revenue

11242000

Cost Of Revenue

1670000

Gross Profit

9572000

Operating Expenses

50287000

Operating Income

-40715000

Interest Expense

-

Pretax Income

-98518000

Net Income

-98518000

Eps

-1.346665390871687

Dividends Per Share

-

Shares Outstanding

73740200

Income Tax Expense

-

EBITDA

-98226000

Operating Margin

-362.16865326454365

Total Other Income Expense Net

-57803000

Cash

137706000

Short Term Investments

-

Receivables

6716000

Inventories

1794000

Total Current Assets

154056000

Property Plant Equipment

750000

Total Assets

176852000

Payables

9888000

Short Term Debt

5103000

Long Term Debt

-

Total Liabilities

192378000

Equity

-15526000

Bs_currency_symbol

-

Depreciation

292000

Change In Working Capital

2864000

Cash From Operations

-36216000

Capital Expenditures

0

Cash From Investing

-8279000

Cash From Financing

17879000

Net Change In Cash

-26616000

Cf_currency_symbol

-

PE

-

PB

-36.140293056807934

ROE

634.5356176735798

ROA

-55.70646642390247

FCF

-36216000

Fcf Percent

-3.221490837929194

Piotroski FScore

1

Health Score

31

Deep Value Investing Score

0.5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

5.3

Garp Investing Score

4.5

Growth Investing Score

4.5

Momentum Investing Score

2

Net Net Investing Score

0.5

Quality Investing Score

2.5

Value Investing Score

2.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

11242000

Quarters > 0 > income Statement > cost Of Revenue

1670000

Quarters > 0 > income Statement > gross Profit

9572000

Quarters > 0 > income Statement > operating Expenses

50287000

Quarters > 0 > income Statement > operating Income

-40715000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-98518000

Quarters > 0 > income Statement > net Income

-98518000

Quarters > 0 > income Statement > eps

-1.346665390871687

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

73157000

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-98226000

Quarters > 0 > income Statement > operating Margin

-362.16865326454365

Quarters > 0 > income Statement > total Other Income Expense Net

-57803000

Quarters > 0 > income Statement > currency_symbol

-

Quarters > 0 > balance Sheet > cash

137706000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

6716000

Quarters > 0 > balance Sheet > inventories

1794000

Quarters > 0 > balance Sheet > total Current Assets

154056000

Quarters > 0 > balance Sheet > property Plant Equipment

750000

Quarters > 0 > balance Sheet > total Assets

176852000

Quarters > 0 > balance Sheet > payables

9888000

Quarters > 0 > balance Sheet > short Term Debt

5103000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

192378000

Quarters > 0 > balance Sheet > equity

-15526000

Quarters > 0 > balance Sheet > currency_symbol

-

Quarters > 0 > cash Flow > net Income

-98518000

Quarters > 0 > cash Flow > depreciation

292000

Quarters > 0 > cash Flow > change In Working Capital

2864000

Quarters > 0 > cash Flow > cash From Operations

-36216000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-8279000

Quarters > 0 > cash Flow > cash From Financing

17879000

Quarters > 0 > cash Flow > net Change In Cash

-26616000

Quarters > 0 > cash Flow > currency_symbol

-

Quarters > 0 > ratios > PE

-1.346665390871687

Quarters > 0 > ratios > PB

-36.140293056807934

Quarters > 0 > ratios > ROE

634.5356176735798

Quarters > 0 > ratios > ROA

-55.70646642390247

Quarters > 0 > ratios > FCF

-36216000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-3.221490837929194

Quarters > 0 > health Score

31

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

2137000

Quarters > 1 > income Statement > cost Of Revenue

446000

Quarters > 1 > income Statement > gross Profit

1691000

Quarters > 1 > income Statement > operating Expenses

45455000

Quarters > 1 > income Statement > operating Income

-43764000

Quarters > 1 > income Statement > interest Expense

212000

Quarters > 1 > income Statement > pretax Income

-25934000

Quarters > 1 > income Statement > net Income

-25934000

Quarters > 1 > income Statement > eps

-0.35028431730080906

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

74037000

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-25594000

Quarters > 1 > income Statement > operating Margin

-2047.9176415535796

Quarters > 1 > income Statement > total Other Income Expense Net

17830000

Quarters > 1 > income Statement > currency_symbol

-

Quarters > 1 > balance Sheet > cash

164322000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

2276000

Quarters > 1 > balance Sheet > inventories

1168000

Quarters > 1 > balance Sheet > total Current Assets

174273000

Quarters > 1 > balance Sheet > property Plant Equipment

984000

Quarters > 1 > balance Sheet > total Assets

196264000

Quarters > 1 > balance Sheet > payables

8047000

Quarters > 1 > balance Sheet > short Term Debt

4178000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

160208000

Quarters > 1 > balance Sheet > equity

36056000

Quarters > 1 > balance Sheet > currency_symbol

-

Quarters > 1 > cash Flow > net Income

-25934000

Quarters > 1 > cash Flow > depreciation

128000

Quarters > 1 > cash Flow > change In Working Capital

8622000

Quarters > 1 > cash Flow > cash From Operations

-32663000

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-

Quarters > 1 > cash Flow > cash From Financing

79416000

Quarters > 1 > cash Flow > net Change In Cash

46753000

Quarters > 1 > cash Flow > currency_symbol

USD

Quarters > 1 > ratios > PE

-0.35028431730080906

Quarters > 1 > ratios > PB

15.749494952296427

Quarters > 1 > ratios > ROE

-71.92700244064788

Quarters > 1 > ratios > ROA

-13.213834427098195

Quarters > 1 > ratios > FCF

-32663000

Quarters > 1 > ratios > Piotroski FScore

0

Quarters > 1 > ratios > fcf Percent

-15.28451099672438

Quarters > 1 > health Score

8

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

-

Quarters > 2 > income Statement > cost Of Revenue

-

Quarters > 2 > income Statement > gross Profit

-

Quarters > 2 > income Statement > operating Expenses

44174000

Quarters > 2 > income Statement > operating Income

-44174000

Quarters > 2 > income Statement > interest Expense

192000

Quarters > 2 > income Statement > pretax Income

-52103000

Quarters > 2 > income Statement > net Income

-52103000

Quarters > 2 > income Statement > eps

-0.9617890831225887

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

54173000

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-51901000

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

-7929000

Quarters > 2 > income Statement > currency_symbol

-

Quarters > 2 > balance Sheet > cash

117569000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

200000

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

124699000

Quarters > 2 > balance Sheet > property Plant Equipment

1210000

Quarters > 2 > balance Sheet > total Assets

131698000

Quarters > 2 > balance Sheet > payables

7199000

Quarters > 2 > balance Sheet > short Term Debt

3029000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

164131000

Quarters > 2 > balance Sheet > equity

-32433000

Quarters > 2 > balance Sheet > currency_symbol

-

Quarters > 2 > cash Flow > net Income

-52103000

Quarters > 2 > cash Flow > depreciation

10000

Quarters > 2 > cash Flow > change In Working Capital

4265000

Quarters > 2 > cash Flow > cash From Operations

-38676000

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

-

Quarters > 2 > cash Flow > cash From Financing

67427000

Quarters > 2 > cash Flow > net Change In Cash

28751000

Quarters > 2 > cash Flow > currency_symbol

USD

Quarters > 2 > ratios > PE

-0.9617890831225887

Quarters > 2 > ratios > PB

-12.811238861653253

Quarters > 2 > ratios > ROE

160.64810532482346

Quarters > 2 > ratios > ROA

-39.562483864599315

Quarters > 2 > ratios > FCF

-38676000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

39

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

-

Quarters > 3 > income Statement > cost Of Revenue

-

Quarters > 3 > income Statement > gross Profit

-

Quarters > 3 > income Statement > operating Expenses

31590000

Quarters > 3 > income Statement > operating Income

-31590000

Quarters > 3 > income Statement > interest Expense

1146000

Quarters > 3 > income Statement > pretax Income

-64366000

Quarters > 3 > income Statement > net Income

-64551000

Quarters > 3 > income Statement > eps

-1.6993589659212067

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

37985500

Quarters > 3 > income Statement > income Tax Expense

185000

Quarters > 3 > income Statement > EBITDA

-63213000

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

-32776000

Quarters > 3 > income Statement > currency_symbol

-

Quarters > 3 > balance Sheet > cash

88818000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

200000

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

94961000

Quarters > 3 > balance Sheet > property Plant Equipment

1437000

Quarters > 3 > balance Sheet > total Assets

101538000

Quarters > 3 > balance Sheet > payables

4026000

Quarters > 3 > balance Sheet > short Term Debt

995000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

130431000

Quarters > 3 > balance Sheet > equity

-28893000

Quarters > 3 > balance Sheet > currency_symbol

-

Quarters > 3 > cash Flow > net Income

-64551000

Quarters > 3 > cash Flow > depreciation

7000

Quarters > 3 > cash Flow > change In Working Capital

4643000

Quarters > 3 > cash Flow > cash From Operations

-25099000

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

-

Quarters > 3 > cash Flow > cash From Financing

742000

Quarters > 3 > cash Flow > net Change In Cash

-24357000

Quarters > 3 > cash Flow > currency_symbol

USD

Quarters > 3 > ratios > PE

-1.6993589659212067

Quarters > 3 > ratios > PB

-10.083715259751497

Quarters > 3 > ratios > ROE

223.41397570345757

Quarters > 3 > ratios > ROA

-63.57324351474325

Quarters > 3 > ratios > FCF

-25099000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

39

Annuals > 0 > quarter

2024-12-31

Annuals > 0 > income Statement > revenue

10000000

Annuals > 0 > income Statement > cost Of Revenue

-

Annuals > 0 > income Statement > gross Profit

10000000

Annuals > 0 > income Statement > operating Expenses

124956000

Annuals > 0 > income Statement > operating Income

-114956000

Annuals > 0 > income Statement > interest Expense

4562000

Annuals > 0 > income Statement > pretax Income

-130452000

Annuals > 0 > income Statement > net Income

-130637000

Annuals > 0 > income Statement > eps

-3.657967686836726

Annuals > 0 > income Statement > dividends Per Share

-

Annuals > 0 > income Statement > shares Outstanding

35713000

Annuals > 0 > income Statement > income Tax Expense

185000

Annuals > 0 > income Statement > EBITDA

-125864000

Annuals > 0 > income Statement > operating Margin

-1149.56

Annuals > 0 > income Statement > total Other Income Expense Net

-15496000

Annuals > 0 > income Statement > currency_symbol

-

Annuals > 0 > balance Sheet > cash

88818000

Annuals > 0 > balance Sheet > short Term Investments

-

Annuals > 0 > balance Sheet > receivables

200000

Annuals > 0 > balance Sheet > inventories

-

Annuals > 0 > balance Sheet > total Current Assets

94961000

Annuals > 0 > balance Sheet > property Plant Equipment

1437000

Annuals > 0 > balance Sheet > total Assets

101538000

Annuals > 0 > balance Sheet > payables

4026000

Annuals > 0 > balance Sheet > short Term Debt

995000

Annuals > 0 > balance Sheet > long Term Debt

-

Annuals > 0 > balance Sheet > total Liabilities

130431000

Annuals > 0 > balance Sheet > equity

-28893000

Annuals > 0 > balance Sheet > currency_symbol

-

Annuals > 0 > cash Flow > net Income

-130637000

Annuals > 0 > cash Flow > depreciation

26000

Annuals > 0 > cash Flow > change In Working Capital

3718000

Annuals > 0 > cash Flow > cash From Operations

-104771000

Annuals > 0 > cash Flow > capital Expenditures

28000

Annuals > 0 > cash Flow > cash From Investing

59972000

Annuals > 0 > cash Flow > cash From Financing

54782000

Annuals > 0 > cash Flow > net Change In Cash

9983000

Annuals > 0 > cash Flow > currency_symbol

-

Annuals > 0 > ratios > PE

-3.657967686836726

Annuals > 0 > ratios > PB

-9.4804523587028

Annuals > 0 > ratios > ROE

452.14065690651717

Annuals > 0 > ratios > ROA

-128.65823632531664

Annuals > 0 > ratios > FCF

-104799000

Annuals > 0 > ratios > Piotroski FScore

0

Annuals > 0 > ratios > fcf Percent

-10.4799

Annuals > 0 > health Score

30

Annuals > 1 > quarter

2023-12-31

Annuals > 1 > income Statement > revenue

-

Annuals > 1 > income Statement > cost Of Revenue

-

Annuals > 1 > income Statement > gross Profit

-

Annuals > 1 > income Statement > operating Expenses

92084000

Annuals > 1 > income Statement > operating Income

-92084000

Annuals > 1 > income Statement > interest Expense

4139000

Annuals > 1 > income Statement > pretax Income

-87367000

Annuals > 1 > income Statement > net Income

-87367000

Annuals > 1 > income Statement > eps

-3.961503582116623

Annuals > 1 > income Statement > dividends Per Share

-

Annuals > 1 > income Statement > shares Outstanding

22054000

Annuals > 1 > income Statement > income Tax Expense

-

Annuals > 1 > income Statement > EBITDA

-83166000

Annuals > 1 > income Statement > operating Margin

-

Annuals > 1 > income Statement > total Other Income Expense Net

4717000

Annuals > 1 > income Statement > currency_symbol

-

Annuals > 1 > balance Sheet > cash

77909000

Annuals > 1 > balance Sheet > short Term Investments

59220000

Annuals > 1 > balance Sheet > receivables

-

Annuals > 1 > balance Sheet > inventories

-

Annuals > 1 > balance Sheet > total Current Assets

143682000

Annuals > 1 > balance Sheet > property Plant Equipment

1208000

Annuals > 1 > balance Sheet > total Assets

149718000

Annuals > 1 > balance Sheet > payables

7184000

Annuals > 1 > balance Sheet > short Term Debt

941000

Annuals > 1 > balance Sheet > long Term Debt

-

Annuals > 1 > balance Sheet > total Liabilities

92344000

Annuals > 1 > balance Sheet > equity

57374000

Annuals > 1 > balance Sheet > currency_symbol

-

Annuals > 1 > cash Flow > net Income

-87367000

Annuals > 1 > cash Flow > depreciation

62000

Annuals > 1 > cash Flow > change In Working Capital

-957000

Annuals > 1 > cash Flow > cash From Operations

-86460000

Annuals > 1 > cash Flow > capital Expenditures

0

Annuals > 1 > cash Flow > cash From Investing

-44447000

Annuals > 1 > cash Flow > cash From Financing

134194000

Annuals > 1 > cash Flow > net Change In Cash

3287000

Annuals > 1 > cash Flow > currency_symbol

USD

Annuals > 1 > ratios > PE

-3.961503582116623

Annuals > 1 > ratios > PB

2.948272388189772

Annuals > 1 > ratios > ROE

-152.27629239725312

Annuals > 1 > ratios > ROA

-58.35437288769554

Annuals > 1 > ratios > FCF

-86460000

Annuals > 1 > ratios > Piotroski FScore

0

Annuals > 1 > ratios > fcf Percent

-

Annuals > 1 > health Score

32

Annuals > 2 > quarter

2022-12-31

Annuals > 2 > income Statement > revenue

2596000

Annuals > 2 > income Statement > cost Of Revenue

-

Annuals > 2 > income Statement > gross Profit

2596000

Annuals > 2 > income Statement > operating Expenses

75533000

Annuals > 2 > income Statement > operating Income

-72937000

Annuals > 2 > income Statement > interest Expense

2137000

Annuals > 2 > income Statement > pretax Income

-73812000

Annuals > 2 > income Statement > net Income

-73812000

Annuals > 2 > income Statement > eps

-4.573800966662535

Annuals > 2 > income Statement > dividends Per Share

-

Annuals > 2 > income Statement > shares Outstanding

16138000

Annuals > 2 > income Statement > income Tax Expense

-

Annuals > 2 > income Statement > EBITDA

-71557000

Annuals > 2 > income Statement > operating Margin

-2809.591679506934

Annuals > 2 > income Statement > total Other Income Expense Net

-875000

Annuals > 2 > income Statement > currency_symbol

-

Annuals > 2 > balance Sheet > cash

74933000

Annuals > 2 > balance Sheet > short Term Investments

12961000

Annuals > 2 > balance Sheet > receivables

31000

Annuals > 2 > balance Sheet > inventories

-

Annuals > 2 > balance Sheet > total Current Assets

92870000

Annuals > 2 > balance Sheet > property Plant Equipment

1881000

Annuals > 2 > balance Sheet > total Assets

95050000

Annuals > 2 > balance Sheet > payables

4901000

Annuals > 2 > balance Sheet > short Term Debt

1069000

Annuals > 2 > balance Sheet > long Term Debt

-

Annuals > 2 > balance Sheet > total Liabilities

47659000

Annuals > 2 > balance Sheet > equity

47391000

Annuals > 2 > balance Sheet > currency_symbol

-

Annuals > 2 > cash Flow > net Income

-73812000

Annuals > 2 > cash Flow > depreciation

-36000

Annuals > 2 > cash Flow > change In Working Capital

3900000

Annuals > 2 > cash Flow > cash From Operations

-63673000

Annuals > 2 > cash Flow > capital Expenditures

0

Annuals > 2 > cash Flow > cash From Investing

66185000

Annuals > 2 > cash Flow > cash From Financing

51784000

Annuals > 2 > cash Flow > net Change In Cash

54296000

Annuals > 2 > cash Flow > currency_symbol

USD

Annuals > 2 > ratios > PE

-4.573800966662535

Annuals > 2 > ratios > PB

2.6118558376062966

Annuals > 2 > ratios > ROE

-155.7510919794898

Annuals > 2 > ratios > ROA

-77.6559705418201

Annuals > 2 > ratios > FCF

-63673000

Annuals > 2 > ratios > Piotroski FScore

0

Annuals > 2 > ratios > fcf Percent

-24.527349768875194

Annuals > 2 > health Score

24

Annuals > 3 > quarter

2021-12-31

Annuals > 3 > income Statement > revenue

2053000

Annuals > 3 > income Statement > cost Of Revenue

-

Annuals > 3 > income Statement > gross Profit

2053000

Annuals > 3 > income Statement > operating Expenses

63462000

Annuals > 3 > income Statement > operating Income

-61409000

Annuals > 3 > income Statement > interest Expense

9972000

Annuals > 3 > income Statement > pretax Income

-71200000

Annuals > 3 > income Statement > net Income

-71200000

Annuals > 3 > income Statement > eps

-4.8989141405436545

Annuals > 3 > income Statement > dividends Per Share

-

Annuals > 3 > income Statement > shares Outstanding

14533833

Annuals > 3 > income Statement > income Tax Expense

-

Annuals > 3 > income Statement > EBITDA

-61156000

Annuals > 3 > income Statement > operating Margin

-2991.1836337067703

Annuals > 3 > income Statement > total Other Income Expense Net

-9791000

Annuals > 3 > income Statement > currency_symbol

-

Annuals > 3 > balance Sheet > cash

21252000

Annuals > 3 > balance Sheet > short Term Investments

79004000

Annuals > 3 > balance Sheet > receivables

516000

Annuals > 3 > balance Sheet > inventories

-

Annuals > 3 > balance Sheet > total Current Assets

105740000

Annuals > 3 > balance Sheet > property Plant Equipment

2512000

Annuals > 3 > balance Sheet > total Assets

108662000

Annuals > 3 > balance Sheet > payables

2302000

Annuals > 3 > balance Sheet > short Term Debt

667000

Annuals > 3 > balance Sheet > long Term Debt

-

Annuals > 3 > balance Sheet > total Liabilities

21103000

Annuals > 3 > balance Sheet > equity

87559000

Annuals > 3 > balance Sheet > currency_symbol

-

Annuals > 3 > cash Flow > net Income

-71200000

Annuals > 3 > cash Flow > depreciation

72000

Annuals > 3 > cash Flow > change In Working Capital

584000

Annuals > 3 > cash Flow > cash From Operations

-53502000

Annuals > 3 > cash Flow > capital Expenditures

196000

Annuals > 3 > cash Flow > cash From Investing

87000

Annuals > 3 > cash Flow > cash From Financing

6885000

Annuals > 3 > cash Flow > net Change In Cash

-46530000

Annuals > 3 > cash Flow > currency_symbol

USD

Annuals > 3 > ratios > PE

-4.8989141405436545

Annuals > 3 > ratios > PB

1.2731358182482668

Annuals > 3 > ratios > ROE

-81.31659795109584

Annuals > 3 > ratios > ROA

-65.52428631904438

Annuals > 3 > ratios > FCF

-53698000

Annuals > 3 > ratios > Piotroski FScore

0

Annuals > 3 > ratios > fcf Percent

-26.155869459327814

Annuals > 3 > health Score

34

Valuation > metrics > PE

-1.346665390871687

Valuation > metrics > PB

-36.140293056807934

Valuation > final Score

50

Valuation > verdict

Fair

Profitability > metrics > ROE

634.5356176735798

Profitability > metrics > ROA

-63.94947291893857

Profitability > metrics > Net Margin

-8.763387297633873

Profitability > final Score

40

Profitability > verdict

Weak

Risk > metrics > Interest Coverage

-139.43493150684932

Risk > final Score

-528

Risk > verdict

High

Liquidity > metrics > Current Ratio

10.276565939563739

Liquidity > metrics > Quick Ratio

10.156894136481888

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

20

Prev Valuations > 1

50

Prev Valuations > 2

50

Prev Profitabilities > 0

0

Prev Profitabilities > 1

55

Prev Profitabilities > 2

55

Prev Risks > 0

-820

Prev Risks > 1

-890

Prev Risks > 2

-80

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2026-01-20T23:14:01.211Z

Earnings History > 0 > period

2025-12-31

Earnings History > 0 > report Date

2026-03-19

Earnings History > 0 > date

2025-12-31

Earnings History > 0 > before After Market

BeforeMarket

Earnings History > 0 > currency

-

Earnings History > 0 > eps Actual

-

Earnings History > 0 > eps Estimate

-0.48

Earnings History > 0 > eps Difference

0

Earnings History > 0 > surprise Percent

-